Integrated Mobile Health Platform for Early Detection in Critical Illness

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial will evaluate an integrated mobile health platform designed to continuously monitor vital signs and urine output in adults with critical illness. It aims to determine if this platform can identify early signals of deterioration and potentially reduce complications such as respiratory, renal, and cardiac issues. The study is interventional and will include ICU patients aged 18 to 65 who require ongoing monitoring and consent to participate. Enrollment is limited to patients staying more than 24 hours in the ICU, excluding those with strict isolation, early mortality, external transfers, or pre-existing severe neurological conditions. The lead sponsor is Sohag University, with the intervention implemented at the Sohag University Hospital ICU.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Adult patients aged 18-65 years.
2. Anticipated ICU stay of more than 24 hours.
3. Clinical requirement and ability to continuously monitor vital signs and urine output.
4. Obtained written informed consent from the patient or their legal guardians.

Exclusion Criteria:

1. Patients placed in strict isolation due to highly infectious diseases.
2. Death within 24 hours of ICU admission.
3. Patients transferred from another external Intensive Care Unit.
4. Re-admission to the ICU during the active study period.
5. Pre-existing chronic altered consciousness or irreversible neurological deficit.
6. Patients who underwent pre-hospital cardiopulmonary resuscitation (CPR).

Where it's running

• Sohag University Hospital, General Intensive Care Unit
  Sohag, Sohag Governorate, Egypt Recruiting

Study contacts

• Study coordinator: Asmaa Yassen, MSc
• Email: asmaayaseen487@gmail.com
• Phone: +201095196756

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Tele-diabetes remote monitoring for kids with type 1 diabetes

  This study tests a tele-diabetes remote system that uses WhatsApp alerts to help children and teens manage their type 1 diabetes at home.

  Recruiting Sheba Medical Center · Ramat Gan · NCT07828106

• Preoperative functional and breathing tests to predict early recovery after colorectal cancer surgery

  We will see if simple preoperative functional and breathing tests can predict early recovery and complications for adults having colorectal cancer surgery.

  Recruiting Inonu University · Malatya · NCT07529301

• Treating infected non-vital baby molars with a zinc oxide/6-gingerol mix versus a triple antibiotic paste

  This trial will test whether a zinc oxide/6-gingerol mix or a triple antibiotic paste better cleans and heals infected non-vital primary molars in children aged 4 to 8.

  Recruiting Al-Azhar University · Cairo · NCT07488416

• Single-layer versus double-layer uterine closure after cesarean and myometrial thickness

  This trial tests whether closing the uterus with one layer or two layers during cesarean leads to thicker, healthier scar tissue in women having a cesarean delivery.

  Recruiting Ankara City Hospital Bilkent · Ankara, Not Valid · NCT07323355

• Omega-3 supplements added to standard TB treatment in adults with pulmonary TB

  This trial tests whether adding omega-3 EPA and DHA to standard TB therapy for 8 weeks helps kill the bacteria faster and reduce inflammation in adults with new, drug-sensitive pulmonary TB.

  Recruiting Phase 2 North-West University, South Africa · Klerksdorp, North West · NCT07118059

• Impact of Nutrition on Cancer Treatment Outcomes in Shaanxi

  This study is testing how a cancer patient's nutrition affects their treatment results and overall well-being during chemotherapy and radiation in Shaanxi Province.

  Recruiting Xi'an Jiaotong University · Xi'an, Shaanxi · NCT06219083

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.